A real-time in-vivo method for studying the percutaneous absorption of volatile chemicals

International Journal of Occupational and Environmental Health

Volumn 6, Issue 2, 2000, Pages 96-103

  Thrall, Karla D ^a   Poet, Torka S ^a   Corley, Richard A ^a   Tanojo, Hanafi ^b   Edwards, Jeffrey A ^a   Weitz, Karl K ^a   Hui, Xiaoying ^b   Maibach, Howard I ^b   Wester, Ronald C ^b  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breath analysis; Human; Monkey; PBPK modeling; Percutaneous absorption; Rat; Volatile organic chemicals

Indexed keywords

VOLATILE AGENT;

ANALYTIC METHOD; ARTICLE; BIOLOGICAL MONITORING; BODY SURFACE; BREATH ANALYSIS; IN VIVO STUDY; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN PENETRATION; VOLATILIZATION; WORKPLACE;

EID: 0034072737     PISSN: 10773525     EISSN: None     Source Type: Journal    
DOI: 10.1179/oeh.2000.6.2.96     Document Type: Article

References (24)

1. Environmental Protection Agency. Exposure Factors Handbook. Washington, DC: EPA/600/P-95/002Ba, 1996.
2. Daniell W, Stebbins A, Kalman D, O'Donnell JF, Horstman SW. The contributions to solvent uptake by skin and inhalation exposure. Am Ind Hyg Assoc J. 1992;53:124-9.
3. Paustenbach DJ, Leung H-W. Techniques for assessing the health risks of dermal contact with chemicals in the environment. In: Wang RGM, Knaak JB, Maibach HI (eds). Health Risk Assessment. Dermal and Inhalation Exposure and Absorption of Toxicants. Boca Raton, FL: CRC Press, 1993:343-86.
4. Corley RA, Gordon SM, Wallace LA. Physiologically based pharmacokinetic modeling of the temperature-dependent dermal absorption of chloroform by humans following bath water exposures. Toxicol Sci. 2000;53:13-23.
5. Poet TS, Thrall KD, Corley RA, et al. Utility of real time breath analysis and physiologically based pharmacokinetic modeling to determine the percutaneous absorption of methyl chloroform in rats and humans. Toxicol Sci. 2000; in press.
6. Gordon SM, Callahan PJ, Kenny DV, Brinkman MC, Wallace LA, Pleil JD. Effect of water temperature on dermal exposure to chloroform. Environ. Health Perspect. 1998;106:337-45.
7. Andersen ME, Krewski D, Withey JR. Physiological pharmacokinetics and cancer risk assessment. Cancer Lett. 1993;69:1-14.
8. Environmental Protection Agency. Dermal Exposure Assessment Principles and Applications. Washington, DC: EPA/600/8-91/011B, 1992.
9. Fiserova-Bergerova V, Pierce JT, Droz PO. Dermal absorption potential of industrial chemicals: criteria for skin notation. Am J Ind Med. 1990;17:617-35.
10. Jepson GW, McDougal JN. Physiologically based modeling on non steady-state dermal absorption of halogenated methanes from an aqueous solution. Toxicol Appl Pharmacol. 1997;144:315-24.
11. Thrall KD, Poet TS, Corley RA. An innovative method to determine percutaneous absorption: real-time breath analysis and physiologically based pharmacokinetic modeling. In: Bronaugh R, Maibach H (eds). Percutaneous Absorption. New York: Marcel Dekker, 1999: 929-37.
12. Gargas ML. An exhaled breath chamber system for assessing rates of metabolism and rates of gastrointestinal absorption with volatile compounds. J Am Coll Toxicol. 1990,9:447-53.
13. Reitz RH, McDougal JN, Himmelstein MW, Nolan RJ, Schumann AM. Physiologically based pharmacokinetic modeling with methylchloroform: implications for interspecies, high dose/low dose, and dose route extrapolations. Toxicol Appl Pharmacol. 1988,95:185-99.
14. Fisher JW, Mahle D, Abbas R. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanl. Toxicol Appl Pharmacol. 1998;152:339-59.
15. Travis CC, Quillen JL, Arms AD. Pharmacokinetics of benzene. Toxicol Appl Pharmacol. 1990;102;400-20.
16. Shatkin J, Szejnwald-Brown H. Pharmacokinetics of the dermal route of exposure to volatile organic chemicals in water: a computer simulation model. Environ Res. 1991;56.90-108.
17. Chinery RL, Gleason AK. A compartmental model for the prediction of breath concentration and absorbed dose of chloroform after exposure while showering. Risk Analysis. 1993;13:51-62.
18. McKone TE. Linking a PBPK model for chloroform with measured breath concentrations in showers: implications for dermal exposure models. J Exposure Analysis Environ Epidemiol. 1993;3:339-65.
19. McDougal JN, Jepson GW, Clewell HJ III, MacNaughton MG, Andersen ME. A physiologically based pharmacokinetic model for dermal absorption of vapors in the rat. Toxicol Appl Pharmacol. 1986;85:286-94.
20. McDougal JN, Jepson GW, Clewell HJ III, Gargas ML, Andersen ME. Dermal absorption of organic chemical vapors in rats and humans. Fund Appl Toxicol. 1990,55:299-308.
21. Bronaugh RL. Current issues in the in vitro measurement of percutaneous absorption. In: Roberts MS, Walters KW (eds). Dermal Absorption and Toxicity Assessment. New York: Marcel Dekker, 1998:155-60.
22. Wester RC, Maibach HI. Regional variation in percutaneous absorption. In: Bronaugh R, Maibach H (eds). Percutaneous Absorption. New York: Marcel Dekker, 1999:107-16.
23. Abdel-Rahman MS, Skowronski GA, Turkall RM. A comparative study of the kinetics and bioavailability of pure and soil-absorbed benzene, toluene, and m-xylene after dermal exposure. In: Wang RGM, Knaak JB, Maibach HI (eds). Health Risk Assessment. Dermal and Inhalation Exposure and Absorption of Toxicants. CRC Press, Boca Raton, FL: CRC Press, 1993: 105-16.
24. Wester RC, Maibach HI. Animal models for percutaneous absorption. In: Wang RGM, Knaak JB, Maibach HI, (eds). Health Risk Assessment. Dermal and Inhalation Exposure and Absorption of Toxicants. Boca Raton, FL: CRC Press, 1993:89-103.